Skip to content
Tuesday, November 17, 2026 · Today’s edition, 6:30 a.m. ETTue, Nov 17 · 6:30 a.m. editionSign inMy Desk 0EditionsSign in
ETF PRO AINovember 17, 2026

XPH SPDR S&P Pharmaceuticals ETF

Fund tearsheet · data as of the latest session · November 17, 2026

Print / save as PDFPrints clean — the site chrome stays behind.

ONE YEAR OF DAILY CLOSES

0.35%expense ratio
$528Mfund assets
+16.7%return, YTD
—return, 1 year
+$50Mnet flow, 1 month
+$263Mnet flow, 1 year
24.5%realized volatility, 1y
-16.5%worst drawdown, 1y
Top ten holdings
1XERS XERIS BIOPHARMA HOLDINGS4.27%
2MANE VERADERMICS INC2.69%
3LLY ELI LILLY2.51%
4PCRX PACIRA BIOSCIENCES2.52%
5VTRS VIATRIS2.48%
6AMRX AMNEAL PHARMACEUTICALS2.49%
7MAZE Maze Therapeutics2.58%
8ZTS ZOETIS2.24%
9RPRX ROYALTY PHARMA2.25%
10PRGO PERRIGO CO2.23%

PREPARED WITH ETF PRO AI · PRIMARY MARKET DATA · INFORMATIONAL ONLY — NOT AN OFFER, RECOMMENDATION, OR INVESTMENT ADVICE · PAST PERFORMANCE DOES NOT GUARANTEE FUTURE RESULTS

ETF Dailyfrom Private Wealth Daily

ETF launches, fund research, and market coverage in your inbox every morning. Free.

Free. Every morning. Unsubscribe from any edition in one click.